Delving into the Latest Updates on Shanghai Zhongyao Biological Technology Co., Ltd. with Synapse

Overview

Tags

Neoplasms

Urogenital Diseases

Herbal medicine

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Neoplasms	1

Top 5 Drug Type	Count

Herbal medicine	1

To evaluate the efficacy and safety of Qizhi capsule combined with abiraterone acetate tablets and prednisone acetate tablets in the treatment of metastatic castration-resistant prostate cancer (stasis-heat internal accumulation syndrome) with PSA progression after treatment with abiraterone acetate tablets and prednisone acetate tablets, and to conduct dose exploration to provide a design basis for subsequent clinical trials.

Start Date-

Sponsor / Collaborator

Shanghai Zhongyao Biological Technology Co., Ltd.

100 Clinical Results associated with Shanghai Zhongyao Biological Technology Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Shanghai Zhongyao Biological Technology Co., Ltd.

Login to view more data

100 Deals associated with Shanghai Zhongyao Biological Technology Co., Ltd.

Login to view more data

100 Translational Medicine associated with Shanghai Zhongyao Biological Technology Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 20 Dec 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 2 Clinical

1

Login to view more data